Starpharma share price charges higher on UK VivaGel BV launch

The Starpharma Holdings Limited (ASX:SPL) share price is pushing higher on Wednesday after announcing the UK launch of its VivaGel BV product…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Starpharma Holdings Limited (ASX: SPL) share price is pushing higher on Wednesday.

In morning trade the dendrimer products developer's shares are up 3% to $1.36.

Why is the Starpharma share price pushing higher?

Investors have been buying Starpharma's shares after it announced that its VivaGel BV product has been launched in the United Kingdom under the brand Betafem BV Gel.

VivaGel BV is a novel, non-antibiotic therapy for the treatment of bacterial vaginosis (BV) and prevention of recurrent BV.

BV is the most common vaginal condition worldwide and twice as common as thrush. One in three women will experience BV and half of these women will have recurrent BV.

Today's news follows the first European launches of the product in June 2019, including in Germany and other countries. It is available over-the-counter in Europe, without the need to see a doctor or obtain a prescription.

Management notes that Europe represents a large commercial opportunity for VivaGel BV, with access to more than 260 million women.

Dr Jackie Fairley, Starpharma CEO, said: "We are delighted to see VivaGel BV launched in the UK. Starpharma and Mundipharma are working closely together to bring this breakthrough product to European women suffering from BV. We look forward to working with Mundipharma on further registrations and launches across the globe."

Mundipharma's CEO, Raman Singh, also spoke positively of the launch.

Singh said: "VivaGel BV is an important addition to the Betadine product portfolio, which continues to evolve to support women's everyday health and well-being around the world. Together with Starpharma we look forward to realising our joint ambition for Betafe and women's health."

The two parties are not resting on their laurels, though. The release explains that they continue to work proactively on regulatory and roll-out activities of VivaGel BV across other Mundipharma's regions.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Starpharma Holdings Limited. The Motley Fool Australia has recommended Starpharma Holdings Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Man pointing an upward line on a bar graph symbolising a rising share price.
Broker Notes

These ASX 200 shares could rise 30% to 70%

Let's see which shares analysts are tipping to generate big returns.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Share Market News

5 fantastic ASX ETFs to buy with $5,000

These funds could be worth a closer look. Here's what you need to know about them.

Read more »

Happy young woman saving money in a piggy bank.
Share Gainers

3 ASX shares that would already have more than doubled your money in 2025

An investment in any of these ASX shares on 2 January would have more than doubled your money by now.

Read more »

woman talking on the phone and giving financial advice whilst analysing the stock market on the computer with a pen
Share Market News

How did your first quarter performance compare to Australian fund managers?

How did you measure up?

Read more »

A man working in the stock exchange.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Broker Notes

10 best shares to buy today in Australia

Analysts think these shares are among the best to buy now.

Read more »

A boy is excited because he won the computer game.
Share Market News

Telix: A masterclass in what this game is all about

Today's market darling reminds us why we love to invest. But is it too late?

Read more »